PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.\', \'Department of Molecular Biology and Endocrinology, VINCA Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.\', \'Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.\', \'Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • E383010.3390/molecules25173830
?:doi
?:hasPublicationType
?:journal
  • Molecules (Basel, Switzerland)
is ?:pmid of
?:pmid
?:pmid
  • 32842509
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32842509>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32842509>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all